Topic in Focus: Naloxone

AMA Ed Hub Logo
Learn more on Naloxone from AMA Ed Hub™.
Red JAMA Logo
Learn more on Naloxone from JAMA Network™.
Illustration of three physicians
6 reasons to join the AMA
Clear Search
·
5 MIN READ

Overdose epidemic requires state action to remove barriers to care

AMA, Mannatt report emphasizes the increasing importance of removing barriers to evidence-based care.

Press Releases
·
4 MIN READ

Nov. 13, 2020: State Advocacy Update 

Public-private partnership seeks to build SUD treatment network throughout Georgia and more in the latest State Advocacy Update.

Advocacy Update
·
1 MIN READ

AMA statement on Justice Department settlement with Purdue Pharma

Any settlement should be used exclusively for data collection, research, education, overdose prevention, stigma elimination, and evidence-based treatment.

Press Releases
·
2 MIN READ

Aug. 28, 2020: State Advocacy Update

Select 2020 research relating to the nation’s drug overdose epidemic in the latest State Advocacy Update.

Advocacy Update
Figure sitting on park bench
·
5 MIN READ

Nation’s drug overdose epidemic requires new policy focus

The nation’s overdose epidemic is being increasingly fueled by illicitly manufactured fentanyl, psychostimulants, heroin, cocaine and drug combinations.

Overdose Epidemic
·
1 MIN READ

AMA applauds FDA for requiring naloxone information on opioid labels

The new labeling can serve as a starting point for discussion between patients and physicians about risks and benefits associated with opioids.

Press Releases
·
5 MIN READ

AMA report shows evolving, deadlier overdose epidemic

AMA cites need to remove barriers to evidence-based care for patients with pain or a substance use disorder.

Press Releases
·
5 MIN READ

July 10, 2020: State Advocacy Update

AMA urges all states to follow Michigan effort to increase access to naloxone and more in the latest State Advocacy Update.

Advocacy Update
UPDATED
·
5 MIN READ

Taking action on opioid use disorder, pain & harm reduction during COVID-19

Policy recommendations focused on pain, opioid use disorder (OUD) and harm reduction to help states during the COVID-19 epidemic.

Overdose Epidemic